Optibiotix Health (OPTI)


Latest News

Technical, regulatory & commercial update

RNS Number: 0749R OptiBiotix Health PLC 19 September 2017 OptiBiotix Health plc ("OptiBiotix" or the "Company") SlimBiome: Technical, Regulatory and Commercial Update OptiB i ot i x H ealth p l c (A I M: O P TI), a li f e sc i ences bu s i n ess d e ve l o p i n g c o m p o u n d s to tack l e o b esi t y, h i g h chole s te r ol, d ia b ete s and skin care, provides the follo...

OptiBiotix Health signs MoU with Bened Biomedical

OptiBiotix Health signed a Memorandum of Understanding (MoU) with Bened Biomedical, Taiwan. The MoU sets the fram...

Strategic partnership with Bened Biomedical

RNS Number: 5525Q OptiBiotix Health PLC 13 September 2017 OptiBiotix Health plc ("OptiBiotix" or "the Company") Strategic partnership with Bened Biomedical OptiBiotix Health Plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol and diabetes, has signed a Memorandum of Understanding ("MoU") with Bened Biomed...

Holding(s) in Company

RNS Number: 3593Q OptiBiotix Health PLC 11 September 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Optibiotix He...

All News

19-09-17Technical, regulatory & commercial updateRNS
13-09-17OptiBiotix Health signs MoU with Bened BiomedicalStockMarketWire
13-09-17Strategic partnership with Bened BiomedicalRNS
11-09-17Holding(s) in CompanyRNS
07-09-17Invited to present at Expoquimia in BarcelonaRNS
06-09-17Investor eveningRNS
05-09-17Manufacturing Agreement with Tata ChemicalsRNS
01-09-17Exercise of Options and Issue of EquityRNS
30-08-17OptiBiotix loss widens on higher expensesStockMarketWire
30-08-17Half-year ReportRNS
24-08-17OptiBiotix Health to launch LPLDL at Supply Side West in USStockMarketWire
24-08-17US product launch of LPLDL? at trade showRNS
22-08-17OptiBiotix seals new deal with SaccoStockMarketWire
22-08-17Global manufacturing & supply agreement with SaccoRNS
31-07-17Total Voting RightsRNS
26-07-17Market launch for LPLDL? capsules in GermanyRNS
17-07-17OptiBiotix Health seals deal with Pharmabiota NZStockMarketWire
17-07-17Supply agreement with Pharmabiota LtdRNS
11-07-17SweetBiotix? development: Results of taste studyRNS
06-07-17Grant of OptionsRNS
15-06-17All resolutions passed at AGM of OptiBiotixStockMarketWire
15-06-17Result of AGMRNS
15-06-17OptiBiotix in supply agreement with HLH BiopharmaStockMarketWire
15-06-17Supply agreement with HLH Biopharma GmbHRNS
31-05-17Holding(s) in CompanyRNS
16-05-17OptiBiotix Health launches LPLDL,SlimBiome productsStockMarketWire
16-05-17Successful launch of LPLDL and SlimBiome productsRNS
09-05-17OptiBiotix notes non-exclusive European licence dealStockMarketWire
09-05-17LPLDL? Non-Exclusive European License AgreementRNS
03-05-17Presentation of abstract at conferenceRNS
25-04-17Optibiotix discusses 'critical' couple of yearsInteractive Investor
25-04-17Optibiotix Health notes first German sales of LPLDLStockMarketWire
25-04-17First German salesRNS
25-04-17OptiBiotix Health marginally widens FY pretax lossStockMarketWire
25-04-17Final ResultsRNS
04-04-17Notice of ResultsRNS
29-03-17UK Investor Show attendanceRNS
24-03-17Holding(s) in CompanyRNS
21-03-17Intention to float SkinBiotherapeuticsRNS
15-03-17Confirmation of Director appointments to the BoardRNS

RSS feeds

  • Editorial news feed for LSE:OPTI Editorial
  • Regulatory news feed for LSE:OPTI Regulatory